Almonty’s Production Startup Sparks a Three-Way Battle: Bulls, Insiders, and a Whiplash Market
Published on 07/14/2026 at 12:12 | Redaktion boerse-global.de
Almonty Industries has reached the moment its investors have been waiting years for — the Sangdong mine in South Korea is now producing saleable tungsten concentrate. But the milestone has unleashed a paradox that is pushing the stock’s annualized 30-day volatility toward 100%: company insiders are liquidating shares at a historic pace while Wall Street analysts raise price targets and the market itself oscillates wildly between euphoria and profit-taking.
The insider selling numbers are staggering. Over the past 90 days, directors and executives have registered net sales totaling $227.6 million, with $75.1 million coming directly from C-suite officers. Director Mark Trachuk alone sold 200,000 shares on July 2 at C$24.07, a transaction worth roughly C$4.8 million that reduced his personal stake by 7.4%. The sales coincide with Almonty’s operational coming-of-age: on July 1, the company began processing a surface stockpile of 139,700 tonnes of ore with a tungsten oxide content of 0.24% to 0.35%, estimated to have a gross value of approximately $68 million. This initial phase is designed to stabilize plant operations before the mine ramps to continuous full production of 4,600 tonnes of concentrate annually.
To finance that ramp, Almonty raised $800 million in June through 2.25% convertible notes due 2031, after underwriters fully exercised their greenshoe option. The initial conversion price sits at roughly $27.40 per share, and net proceeds of $772.7 million are earmarked for debt refinancing and balance-sheet strengthening. The move provides a cushion during the high-cost startup period and received an additional vote of confidence from long-time shareholder Plansee Group, which confirmed a long-term tungsten supply relationship with Sangdong in its FY2025/26 results released July 7.
The analyst community remains broadly supportive despite the insider exodus. DA Davidson led the upgrades, raising its price target from $25 to $33 with a Buy rating. B. Riley Financial earlier boosted its target from $17 to $23, and Bank of America Securities reaffirmed its Buy call. The consensus among six analysts stands at “Moderate Buy,” with an average price target of $21.88 — a level that, from the current Nasdaq price of around $15.50, implies only modest upside. The lone dissenter is Weiss Ratings, which reiterated a “Sell (D-)” rating in June.
Should investors sell immediately? Or is it worth buying Almonty?
CEO Lewis Black used a virtual investor meeting to address the market’s jitters directly. He outlined plans to bring tungsten production back to the United States, noting that Almonty already holds a long-term off-take agreement with the Department of Defense. Black also emphasized the company’s transition to a U.S.-domiciled, full-Nasdaq-reporting issuer. On pricing for critical minerals, he argued that “if you want a functioning supply chain, you need price transparency” and that “the market itself must determine the fair value — it should not depend on subsidies or temporary regulations.”
The tension between these bullish fundamentals and the insider selling has played out in extreme trading. On July 10, the stock surged nearly 11% on Nasdaq to $14.70 and jumped 12.4% in Toronto to C$23.38, boosted by the production news and its inclusion in the Russell 1000 and Russell 3000. But the rally quickly reversed. This Monday, Nasdaq shares slid 6.7% to close at $15.50 on volume of just 1.1 million shares — 79% below the daily average — suggesting profit-taking rather than fresh negative news. Meanwhile, the Toronto listing traded a completely different path, opening at C$22.66 and closing at C$21.24, a gap that highlights how currency effects and disparate liquidity can split the same security’s performance across exchanges.
Since the April 17 peak of C$33.35, the stock has fallen roughly 36% from its 52-week high, though it remains about 14% above its 200-day moving average of C$18.76. The relative strength index, which stood at 48 after Monday’s drop, has since drifted to 41.3 — neither overbought nor oversold. Over the past 12 months, Almonty has still delivered a staggering 227.76% total return, with a year-to-date gain of 77.64%.
Almonty at a turning point? This analysis reveals what investors need to know now.
Financially, the picture is mixed. Market capitalization is $4.29 billion against a negative P/E of -30.03. Liquidity ratios are solid — a quick ratio of 2.37 and current ratio of 2.45 — while debt remains moderate at 0.30 times equity. First-quarter results showed earnings per share of $0.01, matching estimates, and revenue of $18.52 million easily beating the $15.44 million forecast. Yet net margin was a negative 262.29% and return on equity stood at -11.01%, underscoring that profitability has not kept pace with the share price rally.
The question for investors now is how quickly Sangdong’s concentrate can translate into operating cash flow — and whether the insider selling represents opportunistic diversification from a historic high or a deeper concern about valuation. With volatility near 100%, a cross-listed price gap, and a stock that has tripled in a year yet pulled back a third from its peak, Almonty is testing the conviction of even its most bullish backers. The next round of production data and analyst updates will likely determine whether this volatility marks a consolidating base or the start of a more turbulent chapter.
Ad
Almonty Stock: New Analysis - 14 July
Fresh Almonty information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
